Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (51-60 of 349) with videos related to

Pageof 35
Sort By:
Journal of the American College of Cardiology|March 26, 2016
Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?Robert A Henderson, Chris Jarvis, Tim Clayton, et al.
European Heart Journal|October 15, 2024
The win ratio in cardiology trials: lessons learnt, new developments, and wise future useStuart J Pocock, John Gregson, Timothy J Collier, et al.
Journal of the American College of Cardiology|February 6, 2016
Reply: Survival Differences in Clinical Trials With Long-Term Follow-upRobert A Henderson, Chris Jarvis, Tim Clayton, et al.
JAMA|March 9, 2006
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statementGilda Piaggio, Diana R Elbourne, Douglas G Altman, et al.
JAMA|December 27, 2012
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statementGilda Piaggio, Diana R Elbourne, Stuart J Pocock, et al.
Journal of the American College of Cardiology|October 22, 2013
Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)Gregg W Stone, Tim Clayton, Efthymios N Deliargyris, et al.
Journal of the American College of Cardiology|October 30, 2016
Regression to the Mean in SYMPLICITY HTN-3: Implications for Design and Reporting of Future TrialsStuart J Pocock, George Bakris, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|August 20, 2021
Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art ReviewStuart J Pocock, Xavier Rossello, Ruth Owen, et al.
Controlled Clinical Trials|December 10, 2003
An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2x2x2x2x2x2 factorial design (IMPACT)Christian C Apfel, Kari Korttila, Mona Abdalla, et al.
Pulmonary Pharmacology & Therapeutics|January 19, 2010
Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless designPeter J Barnes, Stuart J Pocock, Helgo Magnussen, et al.
Pageof 35

Showing results (51-60 of 349) with videos related to

Sort By:
Pageof 35
Journal of the American College of Cardiology|March 26, 2016
Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?Robert A Henderson, Chris Jarvis, Tim Clayton, et al.
European Heart Journal|October 15, 2024
The win ratio in cardiology trials: lessons learnt, new developments, and wise future useStuart J Pocock, John Gregson, Timothy J Collier, et al.
Journal of the American College of Cardiology|February 6, 2016
Reply: Survival Differences in Clinical Trials With Long-Term Follow-upRobert A Henderson, Chris Jarvis, Tim Clayton, et al.
JAMA|March 9, 2006
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statementGilda Piaggio, Diana R Elbourne, Douglas G Altman, et al.
JAMA|December 27, 2012
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statementGilda Piaggio, Diana R Elbourne, Stuart J Pocock, et al.
Journal of the American College of Cardiology|October 22, 2013
Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)Gregg W Stone, Tim Clayton, Efthymios N Deliargyris, et al.
Journal of the American College of Cardiology|October 30, 2016
Regression to the Mean in SYMPLICITY HTN-3: Implications for Design and Reporting of Future TrialsStuart J Pocock, George Bakris, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|August 20, 2021
Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art ReviewStuart J Pocock, Xavier Rossello, Ruth Owen, et al.
Controlled Clinical Trials|December 10, 2003
An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2x2x2x2x2x2 factorial design (IMPACT)Christian C Apfel, Kari Korttila, Mona Abdalla, et al.
Pulmonary Pharmacology & Therapeutics|January 19, 2010
Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless designPeter J Barnes, Stuart J Pocock, Helgo Magnussen, et al.
Pageof 35